Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

p53

  • Open Access
    P53-armed Oncolytic Adenovirus Enhances the Efficacy of PD-1 Blockade in Neuroblastoma by Inducing Immunogenic Cell Death
    MORIMICHI TANI, HIROSHI TAZAWA, TERUTAKA TANIMOTO, HIROSHI NOUSO, HINAKO WATANABE, TAKANORI OYAMA, YASUO URATA, SHUNSUKE KAGAWA, TAKUO NODA, SHINJI KURODA and TOSHIYOSHI FUJIWARA
    Anticancer Research April 2026, 46 (4) 1769-1784; DOI: https://doi.org/10.21873/anticanres.18073
  • You have access
    Chemosensitizing Effects of Resveratrol Derivatives on p53-dependent Apoptosis Triggered by Cisplatin in Human Lung Cancer Cells
    THANAWUT PRAMUALSIN, ZIN ZIN EI, SATAPAT RACHA, NICHARAT SRIRATANASAK, MASASHI YOKOYA, YUKIHA IIDA and PITHI CHANVORACHOTE
    Anticancer Research April 2026, 46 (4) 1893-1901; DOI: https://doi.org/10.21873/anticanres.18082
  • Open Access
    P53-Armed Oncolytic Virotherapy Promotes the Efficacy of PD1 Blockade in Murine Osteosarcoma Tumors
    MIHO KURE, HIROSHI TAZAWA, KOJI DEMIYA, HIROYA KONDO, YUSUKE MOCHIZUKI, TADASHI KOMATSUBARA, AKI YOSHIDA, KOJI UOTANI, JOE HASEI, TOMOHIRO FUJIWARA, TOSHIYUKI KUNISADA, YASUO URATA, SHUNSUKE KAGAWA, TOSHIFUMI OZAKI and TOSHIYOSHI FUJIWARA
    Anticancer Research January 2026, 46 (1) 69-84; DOI: https://doi.org/10.21873/anticanres.17924
  • You have access
    Pulsed Electromagnetic Field Enhances Caffeic Acid Phenethyl Ester-induced Death of MCF-7 Breast Cancer Cells
    SUNG-HUN WOO, BYUNG CHUL JUNG, JUN-YOUNG KIM, YONG-HEUM LEE and YOON SUK KIM
    Anticancer Research June 2024, 44 (6) 2407-2415; DOI: https://doi.org/10.21873/anticanres.17047
  • You have access
    MRI Texture Analysis of Inguinal Lymph Node Metastasis in Vulvar Cancer – Associations With Histopathology
    JAKOB LEONHARDI, LARS-CHRISTIAN HORN, BAHRIYE AKTAS, TIMM DENECKE, ANNE-KATHRIN HÖHN and HANS-JONAS MEYER
    Anticancer Research June 2024, 44 (6) 2709-2716; DOI: https://doi.org/10.21873/anticanres.17078
  • Open Access
    The Role of SARS-CoV-2 Spike Protein in the Growth of Cervical Cancer Cells
    CONNER M. WILLSON, MARCO LEQUIO, ZIWEN ZHU, MARK R. WAKEFIELD, QIAN BAI, EMERSON FAJARDO, HUAPING XIAO, SAMUEL LEUNG and YUJIANG FANG
    Anticancer Research May 2024, 44 (5) 1807-1815; DOI: https://doi.org/10.21873/anticanres.16982
  • Open Access
    Integration of the Molecular Classification of Endometrial Carcinoma to Select Patients for Fertility Sparing Strategies
    MOHAMED AMINE BANI, AMANDINE MAULARD, PHILIPPE MORICE, CYRUS CHARGARI and CATHERINE GENESTIE
    Anticancer Research February 2024, 44 (2) 445-452; DOI: https://doi.org/10.21873/anticanres.16832
  • Open Access
    Brain Metastases Are Regulated by Immuno-inflammatory Signaling Pathways Governed by STAT3, MAPK and Tumor Suppressor p53 Status: Possible Therapeutic Targets
    SABRINA L. ZELLER, ERIS SPIROLLARI, ALIS J. DICPINIGAITIS, JOHN V. WAINWRIGHT, SIMON J. HANFT, CHIRAG D. GANDHI and MEENA JHANWAR-UNIYAL
    Anticancer Research January 2024, 44 (1) 13-22; DOI: https://doi.org/10.21873/anticanres.16783
  • You have access
    Reduction of HIF-1α/PD-L1 by Catalytic Topoisomerase Inhibitor Induces Cell Death Through Caspase Activation in Cancer Cells Under Hypoxia
    SHOHEI MIYATA, TAKASHI ISHII and SUSUMU KITANAKA
    Anticancer Research January 2024, 44 (1) 49-59; DOI: https://doi.org/10.21873/anticanres.16787
  • You have access
    PHRF1 Promotes Cell Invasion by Modulating SOX4 Expression in Colorectal Cancer HCT116-p53−/− Cells
    HUNG-WEI LIN, TING-WEI SHIH, ADAOBI AMANNA and MAU-SUN CHANG
    Anticancer Research December 2023, 43 (12) 5437-5446; DOI: https://doi.org/10.21873/anticanres.16747

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire